{"id":"https://openalex.org/W2000618519","doi":"https://doi.org/10.1021/jm3017199","title":"Discovery of a Novel Small Molecule Inhibitor Targeting the Frataxin/Ubiquitin Interaction via Structure-Based Virtual Screening and Bioassays","display_name":"Discovery of a Novel Small Molecule Inhibitor Targeting the Frataxin/Ubiquitin Interaction via Structure-Based Virtual Screening and Bioassays","alternate_titles":[],"publication_year":2013,"publication_date":"2013-03-18","ids":{"openalex":"https://openalex.org/W2000618519","doi":"https://doi.org/10.1021/jm3017199","mag":"2000618519","pmid":"https://pubmed.ncbi.nlm.nih.gov/23506486"},"language":"en","primary_location":{"id":"doi:10.1021/jm3017199","doi":"https://doi.org/10.1021/jm3017199","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm3017199","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000618519"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083327774","display_name":"Antonio Lavecchia","orcid":"https://orcid.org/0000-0002-2181-8026","observed_orcids":["https://orcid.org/0000-0002-2181-8026"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Antonio Lavecchia","raw_affiliation_strings":["Dipartimento di Chimica Farmaceutica\re Tossicologica, \u201cDrug Discovery\u201d Laboratory, Universit\u00e0 di Napoli \u201cFederico II\u201d, Via Domenico Montesano 49, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Chimica Farmaceutica\re Tossicologica, \u201cDrug Discovery\u201d Laboratory, Universit\u00e0 di Napoli \u201cFederico II\u201d, Via Domenico Montesano 49, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046232494","display_name":"Carmen Di Giovanni","orcid":"https://orcid.org/0000-0001-6950-4467","observed_orcids":["https://orcid.org/0000-0001-6950-4467"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Carmen Di Giovanni","raw_affiliation_strings":["Dipartimento di Chimica Farmaceutica\re Tossicologica, \u201cDrug Discovery\u201d Laboratory, Universit\u00e0 di Napoli \u201cFederico II\u201d, Via Domenico Montesano 49, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Chimica Farmaceutica\re Tossicologica, \u201cDrug Discovery\u201d Laboratory, Universit\u00e0 di Napoli \u201cFederico II\u201d, Via Domenico Montesano 49, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031786233","display_name":"Carmen Cerchia","orcid":"https://orcid.org/0000-0002-6631-5000","observed_orcids":["https://orcid.org/0000-0002-6631-5000"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Carmen Cerchia","raw_affiliation_strings":["Dipartimento di Chimica Farmaceutica\re Tossicologica, \u201cDrug Discovery\u201d Laboratory, Universit\u00e0 di Napoli \u201cFederico II\u201d, Via Domenico Montesano 49, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Chimica Farmaceutica\re Tossicologica, \u201cDrug Discovery\u201d Laboratory, Universit\u00e0 di Napoli \u201cFederico II\u201d, Via Domenico Montesano 49, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064694057","display_name":"Annapina Russo","orcid":"https://orcid.org/0000-0002-7509-3702","observed_orcids":["https://orcid.org/0000-0002-7509-3702"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Annapina Russo","raw_affiliation_strings":["Dipartimento di Biochimica e Biotecnologie\rMediche, Universit\u00e0 di Napoli \u201cFederico II\u201d, Via Sergio Pansini 5, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Biochimica e Biotecnologie\rMediche, Universit\u00e0 di Napoli \u201cFederico II\u201d, Via Sergio Pansini 5, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039045566","display_name":"Giulia Russo","orcid":"https://orcid.org/0000-0003-3891-3350","observed_orcids":["https://orcid.org/0000-0003-3891-3350"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Russo","raw_affiliation_strings":["Dipartimento di Biochimica e Biotecnologie\rMediche, Universit\u00e0 di Napoli \u201cFederico II\u201d, Via Sergio Pansini 5, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Biochimica e Biotecnologie\rMediche, Universit\u00e0 di Napoli \u201cFederico II\u201d, Via Sergio Pansini 5, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040940946","display_name":"Ettore Novellino","orcid":"https://orcid.org/0000-0002-2181-2142","observed_orcids":["https://orcid.org/0000-0002-2181-2142"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ettore Novellino","raw_affiliation_strings":["Dipartimento di Chimica Farmaceutica\re Tossicologica, \u201cDrug Discovery\u201d Laboratory, Universit\u00e0 di Napoli \u201cFederico II\u201d, Via Domenico Montesano 49, 80131 Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Chimica Farmaceutica\re Tossicologica, \u201cDrug Discovery\u201d Laboratory, Universit\u00e0 di Napoli \u201cFederico II\u201d, Via Domenico Montesano 49, 80131 Napoli, Italy","institution_ids":["https://openalex.org/I71267560"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5083327774"],"corresponding_institution_ids":["https://openalex.org/I71267560"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":3.3769,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.93680634,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"56","issue":"7","first_page":"2861","last_page":"2873"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.5942000150680542,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.5942000150680542,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","score":0.28610000014305115,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.017999999225139618,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/friedreich-ataxia","display_name":"Friedreich's ataxia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/frataxin","display_name":"frataxin","score":1.0},{"id":"https://openalex.org/keywords/ubiquitin-binding-domain","display_name":"ubiquitin-binding domain","score":0.8569999933242798},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.8529999852180481},{"id":"https://openalex.org/keywords/structure-based-virtual-screening","display_name":"structure-based virtual screening","score":0.8379999995231628},{"id":"https://openalex.org/keywords/drug-target-identification","display_name":"drug target identification","score":0.42100000381469727},{"id":"https://openalex.org/keywords/scaffold-based-drug-design","display_name":"scaffold-based drug design","score":0.5019999742507935},{"id":"https://openalex.org/keywords/ligand-binding-assays","display_name":"ligand binding assay","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C2779314966","wikidata":"https://www.wikidata.org/wiki/Q409999","display_name":"Frataxin","level":4,"score":0.9795582294464111},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7950701713562012},{"id":"https://openalex.org/C103697762","wikidata":"https://www.wikidata.org/wiki/Q4112105","display_name":"Virtual screening","level":3,"score":0.7049509882926941},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.6690946221351624},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.5403867363929749},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5057518482208252},{"id":"https://openalex.org/C2780906641","wikidata":"https://www.wikidata.org/wiki/Q213373","display_name":"Ataxia","level":2,"score":0.492093026638031},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.45145097374916077},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3612932562828064},{"id":"https://openalex.org/C2779369046","wikidata":"https://www.wikidata.org/wiki/Q6072234","display_name":"Iron-binding proteins","level":3,"score":0.31308865547180176},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14067566394805908},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.09322795271873474},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000096923","descriptor_name":"Frataxin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001681","descriptor_name":"Biological Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002853","descriptor_name":"Chromatography, Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D025801","descriptor_name":"Ubiquitin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D025801","descriptor_name":"Ubiquitin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D033862","descriptor_name":"Iron-Binding Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D033862","descriptor_name":"Iron-Binding Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm3017199","doi":"https://doi.org/10.1021/jm3017199","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm3017199","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:23506486","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23506486","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W26813210","https://openalex.org/W151049023","https://openalex.org/W1483287406","https://openalex.org/W1512177901","https://openalex.org/W1966055504","https://openalex.org/W1976839484","https://openalex.org/W1979966120","https://openalex.org/W1985469011","https://openalex.org/W1988825354","https://openalex.org/W1990002392","https://openalex.org/W1990773197","https://openalex.org/W1993454528","https://openalex.org/W2006402127","https://openalex.org/W2006430824","https://openalex.org/W2019765911","https://openalex.org/W2021585427","https://openalex.org/W2041091009","https://openalex.org/W2041189078","https://openalex.org/W2043699100","https://openalex.org/W2047468595","https://openalex.org/W2050083547","https://openalex.org/W2051628563","https://openalex.org/W2060102265","https://openalex.org/W2071717945","https://openalex.org/W2078453780","https://openalex.org/W2092581985","https://openalex.org/W2095184629","https://openalex.org/W2099254366","https://openalex.org/W2105822562","https://openalex.org/W2112591915","https://openalex.org/W2119034696","https://openalex.org/W2120039680","https://openalex.org/W2123629694","https://openalex.org/W2124033454","https://openalex.org/W2125078806","https://openalex.org/W2126338957","https://openalex.org/W2130479394","https://openalex.org/W2133622631","https://openalex.org/W2136321020","https://openalex.org/W2140819115","https://openalex.org/W2153983456","https://openalex.org/W2156012420","https://openalex.org/W2156077095","https://openalex.org/W2158155007","https://openalex.org/W2158534713","https://openalex.org/W2171678792","https://openalex.org/W2176516200","https://openalex.org/W2343115548","https://openalex.org/W2989276331","https://openalex.org/W3005146384"],"related_works":["https://openalex.org/W2124033454","https://openalex.org/W6898837306","https://openalex.org/W2113576510","https://openalex.org/W6974168724","https://openalex.org/W2589894933","https://openalex.org/W4304823117","https://openalex.org/W2014929714","https://openalex.org/W4386046082","https://openalex.org/W2094160796","https://openalex.org/W2108689460"],"abstract_inverted_index":{"Friedreich's":[0],"ataxia":[1],"(FRDA)":[2],"is":[3,20,38,47],"an":[4,113],"autosomal":[5],"recessive":[6],"neuro-":[7],"and":[8,44,84,100,105],"cardiodegenerative":[9],"disorder":[10],"for":[11,107,148],"which":[12],"there":[13],"are":[14],"no":[15],"proven":[16],"effective":[17],"treatments.":[18],"FRDA":[19,149],"caused":[21],"by":[22,63,112],"decreased":[23],"expression":[24],"and/or":[25],"function":[26],"of":[27,58,125],"the":[28,41,59,123,134],"mitochondrial":[29],"protein":[30],"frataxin.":[31,79],"Here,":[32],"we":[33,87],"report":[34],"findings":[35],"that":[36,45,141],"frataxin":[37,98,111,142],"degraded":[39],"via":[40],"ubiquitin-proteasomal":[42],"pathway":[43],"it":[46],"ubiquitinated":[48],"at":[49],"residue":[50],"K(147)":[51],"in":[52,78,122,132],"Calu-6":[53],"cells.":[54],"A":[55],"theoretical":[56],"model":[57],"frataxin-K(147)/Ub":[60],"complex,":[61],"constructed":[62],"combining":[64],"bioinformatics":[65],"interface":[66],"predictions":[67],"with":[68,129],"information-driven":[69],"docking,":[70],"revealed":[71],"a":[72,89,126,145],"hitherto":[73],"unnoticed,":[74],"potential":[75,146],"ubiquitin-binding":[76],"domain":[77],"Through":[80],"structure-based":[81],"virtual":[82],"screening":[83],"cell-based":[85],"assays,":[86],"discovered":[88],"novel":[90],"small":[91],"molecule":[92],"(compound":[93],"(+)-11)":[94],"able":[95],"to":[96,110],"prevent":[97],"ubiquitination":[99],"degradation.":[101],"(+)-11":[102],"was":[103],"synthesized":[104],"tested":[106],"specific":[108],"binding":[109],"UF-LC/MS":[114],"based":[115],"ligand-binding":[116],"assay.":[117],"Follow-up":[118],"scaffold-based":[119],"searches":[120],"resulted":[121],"identification":[124],"lead":[127],"series":[128],"micromolar":[130],"activity":[131],"disrupting":[133],"frataxin/Ub":[135],"interaction.":[136],"This":[137],"study":[138],"also":[139],"suggests":[140],"could":[143],"be":[144],"target":[147],"drug":[150],"development.":[151]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000618519","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
